PE  Cresset Partners

https://cressetpartners.com/





     Office Locations:

444 West Lake St, Suite 4700
Chicago, IL 60606
Phone: 312-715-7498

 

Stages:

  • Expansion
  • Middle Market


 

Industries:

  • Business Services
  • Consumer Products & Services
  • Education & Training
  • Financial Services
  • Information Technology
  • Life Sciences & Healthcare

  •  

    Description:

    Cresset Partners, the private investing arm of Cresset Capital Management, makes direct investments in U.S.-based businesses with more than $5 million of EBITDA. The firm has experience investing in financial services, healthcare, technology, education, and a range of business and consumer services and will typically invest $10 million to $100 million. Cresset Partners offers clients direct, often exclusive access to real estate, private equity and secondaries deals. Cresset Partners has over $2.6 billion in committed capital.



    Investment Firm Key

       VC = Venture Capital
       PE = Private Equity
       A = Angel
       I = Incubator
       MB = Merchant Bank
       VD = Venture Debt
       FI = Family Investment Office
       FOF = Fund of Funds
       ED = Economic Development Office   
       TT = Technology Transfer Office
       CVC = Corporate Venture Capital
       SEC = Secondary Purchaser
       HF = Hedge Fund/Mutual Fund
       
       
       
    COMPANY STAGEREVENUE
    Venture Capital
    Seed Stage
    (includes "pre-seed," or
    concept stage)
    No Revenue
    Early StageMinimal
    Revenue
    Growth Stage
    (also called Mid-stage)
    $2M-$7M
    Expansion Stage
    (also called Late-stage)
    $7M and greater
    Private Equity
    Lower Middle Market$10M-$249M
    Middle Market$250M-$499M
    Upper Middle Market$500M-$1B
    Large Cap>$1B
       
       
     

    Investment Team:


    Name   Title
    Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription.
    Chris Boehm Executive Managing Director, Private Capital
    Kate Moulton Chmielewski Managing Director of Marketing

     

    Recent Funding Events (trailing 12 months):


      Date


      Name


      State


      Amount


      Stage


      11/21/2024


      Enveda Biosciences


      CO


      $130,000,000


      Series C


     

    Portfolio companies include:

     

    Recent News: